Hospira Inc. Recall: Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packag
Hospira Inc. Recall: Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packag is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Hospira Inc.; Product: Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), pack
| Recalling firm | Hospira Inc. |
|---|---|
| Product | Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01), packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0703-0110-03); Mfd By: Hospira Inc., Lake Forest, IL 60045; Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618; and b) 1 mL Single-dose Vial, packaged in 10 x 1 mL Single-dose Vials per carton (NDC 0409-2634-01), Hospira, Inc., Lake Forest, IL 60045. |
| Reason for recall | Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide |
| Recall initiated | 20141001 |
| Recall number | D-0044-2015 |
| Category | drug |
| State | IL |
| Country | United States |
$29/mo
Try RecallGuard →